- Home
- CTXR vs EVGR Comparison
CTXR vs EVGR Comparison
Compare CTXR & EVGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTXR
- EVGR
- Stock Information
- Founded
- CTXR 2007
- EVGR 2021
- Country
- CTXR United States
- EVGR Malaysia
- Employees
- CTXR N/A
- EVGR N/A
- Industry
- CTXR Biotechnology: Pharmaceutical Preparations
- EVGR Blank Checks
- Sector
- CTXR Health Care
- EVGR Finance
- Exchange
- CTXR Nasdaq
- EVGR Nasdaq
- Market Cap
- CTXR 84.9M
- EVGR 94.7M
- IPO Year
- CTXR N/A
- EVGR 2022
- Fundamental
- Price
- CTXR $0.20
- EVGR $11.75
- Analyst Decision
- CTXR Strong Buy
- EVGR
- Analyst Count
- CTXR 2
- EVGR 0
- Target Price
- CTXR $5.00
- EVGR N/A
- AVG Volume (30 Days)
- CTXR 2.0M
- EVGR 1.5K
- Earning Date
- CTXR 12-27-2024
- EVGR 10-10-2024
- Dividend Yield
- CTXR N/A
- EVGR N/A
- EPS Growth
- CTXR N/A
- EVGR 3.29
- EPS
- CTXR N/A
- EVGR 0.28
- Revenue
- CTXR N/A
- EVGR N/A
- Revenue This Year
- CTXR N/A
- EVGR N/A
- Revenue Next Year
- CTXR N/A
- EVGR N/A
- P/E Ratio
- CTXR N/A
- EVGR $42.22
- Revenue Growth
- CTXR N/A
- EVGR N/A
- 52 Week Low
- CTXR $0.19
- EVGR $11.05
- 52 Week High
- CTXR $1.07
- EVGR $11.79
- Technical
- Relative Strength Index (RSI)
- CTXR 29.06
- EVGR 51.96
- Support Level
- CTXR $0.31
- EVGR $11.73
- Resistance Level
- CTXR $0.51
- EVGR $11.78
- Average True Range (ATR)
- CTXR 0.06
- EVGR 0.00
- MACD
- CTXR -0.01
- EVGR -0.01
- Stochastic Oscillator
- CTXR 3.83
- EVGR 40.00
About CTXR Citius Pharmaceuticals Inc.
Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. It is currently advancing four proprietary product candidates: LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma . Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory distress syndrome.
About EVGR Evergreen Corporation
Evergreen Corp is a blank check company.